Semin Respir Crit Care Med 2014; 35(03): 336-351
DOI: 10.1055/s-0034-1381229
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Clinical Presentation of Sarcoidosis and Diagnostic Work-Up

Dominique Valeyre
1   Pneumology Department, Avicenne Universitary Hospital, Bobigny, France
2   Université Paris 13, Sorbonne Paris Cité, EA 2363, Hypoxie et poumon, Bobigny, France
,
Jean-François Bernaudin
3   Histology and Cytology Department, Tenon Universitary Hospital, Paris, France
,
Yurdagul Uzunhan
1   Pneumology Department, Avicenne Universitary Hospital, Bobigny, France
2   Université Paris 13, Sorbonne Paris Cité, EA 2363, Hypoxie et poumon, Bobigny, France
,
Marianne Kambouchner
4   Pathology Department, Avicenne Universitary Hospital, Bobigny, France
,
Pierre-Yves Brillet
2   Université Paris 13, Sorbonne Paris Cité, EA 2363, Hypoxie et poumon, Bobigny, France
5   Radiology Department, Avicenne Universitary Hospital, Bobigny, France
,
Michael Soussan
6   Nuclear Medicine Department, Avicenne Universitary Hospital, Bobigny, France
,
Hilario Nunes
1   Pneumology Department, Avicenne Universitary Hospital, Bobigny, France
2   Université Paris 13, Sorbonne Paris Cité, EA 2363, Hypoxie et poumon, Bobigny, France
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2014 (online)

Abstract

Sarcoidosis is a systemic disease of unknown cause characterized by the formation of immune granulomas which most often involve the lung and the lymphatic system. Sarcoidosis may encompass numerous different clinical presentations. Typical presentations often prompt a rapid diagnosis while in 25 to 50% of cases, diverse and less typical presentations may lead to delayed diagnosis. The mediastinopulmonary sphere is involved in 85 to 95% of cases, associated with extrapulmonary localizations in half of cases while extrapulmonary localizations without lung involvement may be seen in 5 to 15% of cases. Bilateral hilar lymphadenopathy is the most typical sign at chest radiography. Computed tomography (CT) is essential face for atypical manifestations of the disease to avoid confusion with differential diagnoses and, sometimes, comorbidities. CT typically evidences diffuse pulmonary perilymphatic micronodules, with a perilobular and fissural distribution and upper and posterior predominance, even when an atypical CT pattern is predominant. CT allows deciphering pulmonary lesions in cases of pulmonary fibrosis, pulmonary hypertension, and airflow limitation. Pulmonary function tests generally correlate with the overall disease process. Forced vital capacity is the simplest and most accurate parameter to reflect the impact of pulmonary sarcoidosis. Cardiopulmonary exercise testing helps in understanding the mechanism behind dyspnea of uncertain origin. Endoscopic transbronchial needle aspiration is an extra tool to support diagnosis in addition to more classical biopsy means. Bronchoalveolar lavage (BAL) may be used for individual patients while it is not really decisive for the diagnosis of sarcoidosis for most patients. Diagnosis relies on compatible clinical and radiological presentation, evidence of noncaseating granulomas and exclusion of other diseases with a similar presentation or histology. The probability of diagnosis at presentation is variable from case to case and may often be reinforced with time. Some investigations are mandatory at diagnosis to assess organ involvement and disease activity. However, there are important variations in diagnostic work-up due to diverse expressions of sarcoidosis and differences in clinical practices among physicians.

 
  • References

  • 1 Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160 (2) 736-755
  • 2 Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J. Sarcoidosis. Lancet 2014; 383: 1155-1167
  • 3 Prasse A, Katic C, Germann M, Buchwald A, Zissel G, Müller-Quernheim J. Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med 2008; 177 (3) 330-336
  • 4 Rockoff SD, Rohatgi PK. Unusual manifestations of thoracic sarcoidosis. AJR Am J Roentgenol 1985; 144 (3) 513-528
  • 5 Judson MA, Thompson BW, Rabin DL , et al; ACCESS Research Group. The diagnostic pathway to sarcoidosis. Chest 2003; 123 (2) 406-412
  • 6 Lynch III JP, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clin Chest Med 1997; 18 (4) 755-785
  • 7 Baughman RP, Teirstein AS, Judson MA , et al; Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164 (10 Pt 1) 1885-1889
  • 8 Drent M, Lower EE, De Vries J. Sarcoidosis-associated fatigue. Eur Respir J 2012; 40 (1) 255-263
  • 9 Hillerdal G, Nöu E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984; 130 (1) 29-32
  • 10 Morimoto T, Azuma A, Abe S , et al. Epidemiology of sarcoidosis in Japan. Eur Respir J 2008; 31 (2) 372-379
  • 11 Varron L, Cottin V, Schott AM, Broussolle C, Sève P. Late-onset sarcoidosis: a comparative study. Medicine (Baltimore) 2012; 91 (3) 137-143
  • 12 Rybicki BA, Iannuzzi MC, Frederick MM , et al; ACCESS Research Group. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001; 164 (11) 2085-2091
  • 13 Mañá J, Gómez-Vaquero C, Montero A , et al. Löfgren's syndrome revisited: a study of 186 patients. Am J Med 1999; 107 (3) 240-245
  • 14 Cadelis G, Cordel N, Coquart N, Etienne N, Macal M. Incidence of sarcoidosis in Guadeloupe. A 13-year retrospective study: 1997-2009 [in French]. Rev Mal Respir 2012; 29 (1) 13-20
  • 15 Reich JM, Johnson RE. Course and prognosis of sarcoidosis in a nonreferral setting. Analysis of 86 patients observed for 10 years. Am J Med 1985; 78 (1) 61-67
  • 16 Nardi A, Brillet PY, Letoumelin P , et al. Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J 2011; 38 (6) 1368-1373
  • 17 Grunewald J, Eklund A. Sex-specific manifestations of Löfgren's syndrome. Am J Respir Crit Care Med 2007; 175 (1) 40-44
  • 18 Judson MA. Extrapulmonary sarcoidosis. Semin Respir Crit Care Med 2007; 28 (1) 83-101
  • 19 Mahévas M, Lescure FX, Boffa JJ , et al. Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore) 2009; 88 (2) 98-106
  • 20 Bouvry D, Mouthon L, Brillet PY , et al; Groupe Sarcoïdose Francophone. Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis. Eur Respir J 2013; 41 (1) 115-122
  • 21 Naccache JM, Lavolé A, Nunes H , et al. High-resolution computed tomographic imaging of airways in sarcoidosis patients with airflow obstruction. J Comput Assist Tomogr 2008; 32 (6) 905-912
  • 22 Chambellan A, Turbie P, Nunes H, Brauner M, Battesti JP, Valeyre D. Endoluminal stenosis of proximal bronchi in sarcoidosis: bronchoscopy, function, and evolution. Chest 2005; 127 (2) 472-481
  • 23 Grenier P, Chevret S, Beigelman C, Brauner MW, Chastang C, Valeyre D. Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis. Radiology 1994; 191 (2) 383-390
  • 24 Bein ME, Putman CE, McLoud TC, Mink JH. A reevaluation of intrathoracic lymphadenopathy in sarcoidosis. AJR Am J Roentgenol 1978; 131 (3) 409-415
  • 25 Criado E, Sánchez M, Ramírez J , et al. Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics 2010; 30 (6) 1567-1586
  • 26 Bergin CJ, Bell DY, Coblentz CL , et al. Sarcoidosis: correlation of pulmonary parenchymal pattern at CT with results of pulmonary function tests. Radiology 1989; 171 (3) 619-624
  • 27 Lynch III JP. Computed tomographic scanning in sarcoidosis. Semin Respir Crit Care Med 2003; 24 (4) 393-418
  • 28 Brauner MW, Grenier P, Mompoint D, Lenoir S, de Crémoux H. Pulmonary sarcoidosis: evaluation with high-resolution CT. Radiology 1989; 172 (2) 467-471
  • 29 Hours S, Nunes H, Kambouchner M , et al. Pulmonary cavitary sarcoidosis: clinico-radiologic characteristics and natural history of a rare form of sarcoidosis. Medicine (Baltimore) 2008; 87 (3) 142-151
  • 30 Martin SG, Kronek LP, Valeyre D , et al. High-resolution computed tomography to differentiate chronic diffuse interstitial lung diseases with predominant ground-glass pattern using logical analysis of data. Eur Radiol 2010; 20 (6) 1297-1310
  • 31 Nunes H, Uzunhan Y, Gille T, Lamberto C, Valeyre D, Brillet PY. Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function. Eur Respir J 2012; 40 (3) 750-765
  • 32 Abehsera M, Valeyre D, Grenier P, Jaillet H, Battesti JP, Brauner MW. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 2000; 174 (6) 1751-1757
  • 33 Hansell DM, Milne DG, Wilsher ML, Wells AU. Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT. Radiology 1998; 209 (3) 697-704
  • 34 Devaraj A, Wells AU, Meister MG, Corte TJ, Hansell DM. The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. Radiology 2008; 249 (3) 1042-1049
  • 35 Zisman DA, Karlamangla AS, Ross DJ , et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007; 132 (3) 773-779
  • 36 Nunes H, Humbert M, Capron F , et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006; 61 (1) 68-74
  • 37 Crawshaw AP, Wotton CJ, Yeates DG, Goldacre MJ, Ho LP. Evidence for association between sarcoidosis and pulmonary embolism from 35-year record linkage study. Thorax 2011; 66 (5) 447-448
  • 38 Swigris JJ, Olson AL, Huie TJ , et al. Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007. Chest 2011; 140 (5) 1261-1266
  • 39 Erdal BS, Crouser ED, Yildiz V , et al. Quantitative computerized two-point correlation analysis of lung CT scans correlates with pulmonary function in pulmonary sarcoidosis. Chest 2012; 142 (6) 1589-1597
  • 40 Gaeta M, Blandino A, Scribano E , et al. Chronic infiltrative lung diseases: value of gadolinium-enhanced MRI in the evaluation of disease activity—early report. Chest 2000; 117 (4) 1173-1178
  • 41 Israel HL, Albertine KH, Park CH, Patrick H. Whole-body gallium 67 scans. Role in diagnosis of sarcoidosis. Am Rev Respir Dis 1991; 144 (5) 1182-1186
  • 42 Lebtahi R, Crestani B, Belmatoug N , et al. Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis. J Nucl Med 2001; 42 (1) 21-26
  • 43 Keijsers RG, van den Heuvel DA, Grutters JC. Imaging the inflammatory activity of sarcoidosis. Eur Respir J 2013; 41 (3) 743-751
  • 44 Teirstein AS, Machac J, Almeida O, Lu P, Padilla ML, Iannuzzi MC. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007; 132 (6) 1949-1953
  • 45 Huang ZB, Eden E. Effect of bronchoalveolar lavage fluid from patients with sarcoidosis or AIDS on interleukin 1 beta release from alveolar macrophages. Chest 1990; 98 (3) 576-580
  • 46 Keogh BA, Crystal RG. Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us?. Chest 1980; 78 (6) 856-865
  • 47 Zappala CJ, Desai SR, Copley SJ , et al. Accuracy of individual variables in the monitoring of long-term change in pulmonary sarcoidosis, as judged by serial HRCT data. Chest 2014; 145: 101-107
  • 48 Lamberto C, Nunes H, Le Toumelin P, Duperron F, Valeyre D, Clerici C. Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange. Chest 2004; 125 (6) 2061-2068
  • 49 Sharma SK, Verma U, Pande JN, Murugesan K, Verma K, Guleria JS. Glucocorticoid receptors in bronchoalveolar lavage fluid in sarcoidosis. A preliminary report. Chest 1988; 93 (3) 577-579
  • 50 Lavergne F, Clerici C, Sadoun D, Brauner M, Battesti JP, Valeyre D. Airway obstruction in bronchial sarcoidosis: outcome with treatment. Chest 1999; 116 (5) 1194-1199
  • 51 Udwadia ZF, Pilling JR, Jenkins PF, Harrison BD. Bronchoscopic and bronchographic findings in 12 patients with sarcoidosis and severe or progressive airways obstruction. Thorax 1990; 45 (4) 272-275
  • 52 Baughman RP, Sparkman BK, Lower EE. Six-minute walk test and health status assessment in sarcoidosis. Chest 2007; 132 (1) 207-213
  • 53 Delobbe A, Perrault H, Maitre J , et al. Impaired exercise response in sarcoid patients with normal pulmonary functio. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19 (2) 148-153
  • 54 Marcellis RG, Lenssen AF, de Vries GJ , et al. Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients?. Lung 2013; 191 (1) 43-52
  • 55 Wallaert B, Talleu C, Wemeau-Stervinou L, Duhamel A, Robin S, Aguilaniu B. Reduction of maximal oxygen uptake in sarcoidosis: relationship with disease severity. Respiration 2011; 82 (6) 501-508
  • 56 Lopes AJ, Menezes SL, Dias CM, Oliveira JF, Mainenti MR, Guimarães FS. Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis. Braz J Med Biol Res 2012; 45 (3) 256-263
  • 57 Kollert F, Geck B, Suchy R , et al. The impact of gas exchange measurement during exercise in pulmonary sarcoidosis. Respir Med 2011; 105 (1) 122-129
  • 58 Chapman JT, Mehta AC. Bronchoscopy in sarcoidosis: diagnostic and therapeutic interventions. Curr Opin Pulm Med 2003; 9 (5) 402-407
  • 59 Lenique F, Brauner MW, Grenier P, Battesti JP, Loiseau A, Valeyre D. CT assessment of bronchi in sarcoidosis: endoscopic and pathologic correlations. Radiology 1995; 194 (2) 419-423
  • 60 Polychronopoulos VS, Prakash UB. Airway involvement in sarcoidosis. Chest 2009; 136 (5) 1371-1380
  • 61 de Boer S, Milne DG, Zeng I, Wilsher ML. Does CT scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis?. Thorax 2009; 64 (5) 436-439
  • 62 Fritscher-Ravens A, Mylonaki M, Pantes A, Topalidis T, Thonke F, Swain P. Endoscopic ultrasound-guided biopsy for the diagnosis of focal lesions of the spleen. Am J Gastroenterol 2003; 98 (5) 1022-1027
  • 63 Garwood S, Judson MA, Silvestri G, Hoda R, Fraig M, Doelken P. Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. Chest 2007; 132 (4) 1298-1304
  • 64 Oki M, Saka H, Kitagawa C , et al. Prospective study of endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes versus transbronchial lung biopsy of lung tissue for diagnosis of sarcoidosis. J Thorac Cardiovasc Surg 2012; 143 (6) 1324-1329
  • 65 Tournoy KG, Bolly A, Aerts JG , et al. The value of endoscopic ultrasound after bronchoscopy to diagnose thoracic sarcoidosis. Eur Respir J 2010; 35 (6) 1329-1335
  • 66 Tremblay A, Stather DR, Maceachern P, Khalil M, Field SK. A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis. Chest 2009; 136 (2) 340-346
  • 67 von Bartheld MB, Dekkers OM, Szlubowski A , et al. Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial. JAMA 2013; 309 (23) 2457-2464
  • 68 Plit ML, Havryk AP, Hodgson A , et al. Rapid cytological analysis of endobronchial ultrasound-guided aspirates in sarcoidosis. Eur Respir J 2013; 42 (5) 1302-1308
  • 69 Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984; 310 (4) 235-244
  • 70 Costabel U, Bonella F, Ohshimo S, Guzman J. Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET. Semin Respir Crit Care Med 2010; 31 (4) 404-408
  • 71 Kolopp-Sarda MN, Kohler C, De March AK, Béné MC, Faure G. Discriminative immunophenotype of bronchoalveolar lavage CD4 lymphocytes in sarcoidosis. Lab Invest 2000; 80 (7) 1065-1069
  • 72 Heron M, Slieker WA, Zanen P , et al. Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis. Clin Immunol 2008; 126 (3) 338-344
  • 73 Hyldgaard C, Kaae S, Riddervold M, Hoffmann HJ, Hilberg O. Value of s-ACE, BAL lymphocytosis, and CD4+/CD8+ and CD103+CD4+/CD4+ T-cell ratios in diagnosis of sarcoidosis. Eur Respir J 2012; 39 (4) 1037-1039
  • 74 Wells AU. The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease. Eur Respir Rev 2010; 19 (117) 237-241
  • 75 Drent M, van Nierop MA, Gerritsen FA, Wouters EF, Mulder PG. A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 1996; 153 (2) 736-741
  • 76 Welker L, Jörres RA, Costabel U, Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 2004; 24 (6) 1000-1006
  • 77 Myers JL, Tazelaar HD. Challenges in pulmonary fibrosis: 6—Problematic granulomatous lung disease. Thorax 2008; 63 (1) 78-84
  • 78 Travis WDCT, Koss MN, Rosado-de-Christenson ML, Muller NL, King TEJ. Non-Neoplastic Disorders of the Lower Respiratory Tract. Washington, DC: American Registry of Pathology and the Armed Forces Institute of Pathology; 2002: 123-36
  • 79 Soler P, Basset F, Bernaudin JF, Chretien J. Morphology and distribution of the cells of a sarcoid granuloma: ultrastructural study of serial sections. Ann N Y Acad Sci 1976; 278: 147-160
  • 80 Silverstein E, Pertschuk LP, Friedland J. Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas. Proc Natl Acad Sci U S A 1979; 76 (12) 6646-6648
  • 81 Ishizuka S, Matsui T, Nakao Y , et al. Metabolism of 25-hydroxycholecalciferol in human promyelocytic leukemia cells (HL-60). Isolation and identification of (5Z)- and (5E)-19-nor-10-oxo-25-hydroxycholecalciferol. Eur J Biochem 1986; 161 (1) 233-239
  • 82 Miyara M, Amoura Z, Parizot C , et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006; 203 (2) 359-370
  • 83 Facco M, Cabrelle A, Teramo A , et al. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax 2011; 66 (2) 144-150
  • 84 Kamphuis LS, van Zelm MC, Lam KH , et al. Perigranuloma localization and abnormal maturation of B cells: emerging key players in sarcoidosis?. Am J Respir Crit Care Med 2013; 187 (4) 406-416
  • 85 Cheung OY, Muhm JR, Helmers RA , et al. Surgical pathology of granulomatous interstitial pneumonia. Ann Diagn Pathol 2003; 7 (2) 127-138
  • 86 Carrington CB. Structure and function in sarcoidosis. Ann N Y Acad Sci 1976; 278: 265-283
  • 87 Keogh BA, Crystal RG. Alveolitis: the key to the interstitial lung disorders. Thorax 1982; 37 (1) 1-10
  • 88 Lacronique J, Bernaudin JF, Soler P , et al. Alveolitis and granulomas: sequential course in pulmonary sarcoidosis. In: Chretien J, Marsac J, Saltiel JC, , eds. Sarcoidosis and other granulomatous disorders. Ninth international conference on sarcoidosis and other granulomatous disorders. Paris: Pergamon Press; 1983: 36-42
  • 89 Rosen Y, Athanassiades TJ, Moon S, Lyons HA. Nongranulomatous interstitial pneumonitis in sarcoidosis. Relationship to development of epithelioid granulomas. Chest 1978; 74 (2) 122-125
  • 90 Müller-Quernheim J, Prasse A, Zissel G. Pathogenesis of sarcoidosis. Presse Med 2012; 41 (6 Pt 2) e275-e287
  • 91 Capelli A, Di Stefano A, Lusuardi M, Gnemmi I, Donner CF. Increased macrophage inflammatory protein-1alpha and macrophage inflammatory protein-1beta levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis. Am J Respir Crit Care Med 2002; 165 (2) 236-241
  • 92 Planès C, Valeyre D, Loiseau A, Bernaudin JF, Soler P. Ultrastructural alterations of the air-blood barrier in sarcoidosis and hypersensitivity pneumonitis and their relation to lung histopathology. Am J Respir Crit Care Med 1994; 150 (4) 1067-1074
  • 93 Shigemitsu H. Is sarcoidosis frequent in patients with cancer?. Curr Opin Pulm Med 2008; 14 (5) 478-480
  • 94 Xu L, Kligerman S, Burke A. End-stage sarcoid lung disease is distinct from usual interstitial pneumonia. Am J Surg Pathol 2013; 37 (4) 593-600
  • 95 Lockstone HE, Sanderson S, Kulakova N , et al. Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis. Am J Respir Crit Care Med 2010; 181 (12) 1367-1375
  • 96 Patterson KC, Hogarth K, Husain AN, Sperling AI, Niewold TB. The clinical and immunologic features of pulmonary fibrosis in sarcoidosis. Transl Res 2012; 160 (5) 321-331
  • 97 Shigemitsu H, Oblad JM, Sharma OP, Koss MN. Chronic interstitial pneumonitis in end-stage sarcoidosis. Eur Respir J 2010; 35 (3) 695-697
  • 98 Takemura T, Matsui Y, Saiki S, Mikami R. Pulmonary vascular involvement in sarcoidosis: a report of 40 autopsy cases. Hum Pathol 1992; 23 (11) 1216-1223
  • 99 Corte TJ, Wells AU, Nicholson AG, Hansell DM, Wort SJ. Pulmonary hypertension in sarcoidosis: a review. Respirology 2011; 16 (1) 69-77
  • 100 Patel AS, Siegert RJ, Creamer D , et al. The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status. Thorax 2013; 68 (1) 57-65
  • 101 De Vries J, Michielsen H, Van Heck GL, Drent M. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br J Health Psychol 2004; 9 (Pt 3) 279-291
  • 102 De Vries J, Lower EE, Drent M. Quality of life in sarcoidosis: assessment and management. Semin Respir Crit Care Med 2010; 31 (4) 485-493
  • 103 Elfferich MD, Nelemans PJ, Ponds RW, De Vries J, Wijnen PA, Drent M. Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment. Respiration 2010; 80 (3) 212-219
  • 104 Mahévas M, Chiche L, Uzunhan Y , et al. Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients. Medicine (Baltimore) 2011; 90 (4) 269-278
  • 105 Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet 2008; 372 (9637) 489-502
  • 106 Quaden C, Tillie-Leblond I, Delobbe A , et al. Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluations. Eur Respir J 2005; 26 (5) 778-785
  • 107 Cremers J, Drent M, Driessen A , et al. Liver-test abnormalities in sarcoidosis. Eur J Gastroenterol Hepatol 2012; 24 (1) 17-24
  • 108 Magrì D, Agostoni P, Ricotta A , et al. NT-proatrial natriuretic peptide as a possible biomarker of cardiopulmonary involvement in sarcoidosis. Eur J Intern Med 2013; 24 (3) 278-284
  • 109 Bihan H, Christozova V, Dumas JL , et al. Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in 9 patients and review of the literature. Medicine (Baltimore) 2007; 86 (5) 259-268
  • 110 Harrell GT, Fisher S. Blood chemical changes in Boeck's sarcoid with particular reference to protein, calcium and phosphatase values. J Clin Invest 1939; 18 (6) 687-693
  • 111 Baughman RP, Janovcik J, Ray Et Al M. Calcium and vitamin D metabolism in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2013; 30 (2) 113-120
  • 112 Sharma OP. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med 2000; 6 (5) 442-447
  • 113 Meyrier A, Valeyre D, Bouillon R, Paillard F, Battesti JP, Georges R. Resorptive versus absorptive hypercalciuria in sarcoidosis: correlations with 25-hydroxy vitamin D3 and 1,25-dihydroxy vitamin D3 and parameters of disease activity. Q J Med 1985; 54 (215) 269-281
  • 114 Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med 1975; 59 (3) 365-372
  • 115 Biller H, Zissel G, Ruprecht B, Nauck M, Busse Grawitz A, Müller-Quernheim J. Genotype-corrected reference values for serum angiotensin-converting enzyme. Eur Respir J 2006; 28 (6) 1085-1090
  • 116 Romer FK. Angiotensin-converting enzyme activity in sarcoidosis and other disorders. Sarcoidosis 1985; 2 (1) 25-34
  • 117 Studdy PR, Lapworth R, Bird R. Angiotensin-converting enzyme and its clinical significance—a review. J Clin Pathol 1983; 36 (8) 938-947
  • 118 Marchand-Adam S, Guillon F, Brauner M, Valeyre D. Chronic beryllium disease: a model of interaction between environmental exposure and genetic predisposition. Pathogenesis and clinical features (Part 2) [in French]. Rev Mal Respir 2005; 22 (2 Pt 1) 271-287
  • 119 Ramos-Casals M, Mañá J, Nardi N , et al; HISPAMEC Study Group. Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases. Medicine (Baltimore) 2005; 84 (2) 69-80
  • 120 Bargagli E, Bennett D, Maggiorelli C , et al. Human chitotriosidase: a sensitive biomarker of sarcoidosis. J Clin Immunol 2013; 33 (1) 264-270
  • 121 Paone G, Leone A, Batzella S , et al. Use of discriminant analysis in assessing pulmonary function worsening in patients with sarcoidosis by a panel of inflammatory biomarkers. Inflamm Res 2013; 62 (3) 325-332
  • 122 Zhou T, Zhang W, Sweiss NJ , et al. Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis. PLoS ONE 2012; 7 (9) e44818
  • 123 Gupta D, Kumar S, Aggarwal AN, Verma I, Agarwal R. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection. Sarcoidosis Vasc Diffuse Lung Dis 2011; 28 (2) 95-101
  • 124 Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 2011; 183 (5) 573-581
  • 125 Winterbauer RH, Belic N, Moores KD. Clinical interpretation of bilateral hilar adenopathy. Ann Intern Med 1973; 78 (1) 65-71
  • 126 Nessan VJ, Jacoway JR. Biopsy of minor salivary glands in the diagnosis of sarcoidosis. N Engl J Med 1979; 301 (17) 922-924
  • 127 Tabak L, Ağirbaş E, Yilmazbayhan D, Tanyeri H, Güç U. The value of labial biopsy in the differentiation of sarcoidosis from tuberculosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18 (2) 191-195
  • 128 Blaise P, Fardeau C, Chapelon C, Bodaghi B, Le Hoang P. Minor salivary gland biopsy in diagnosing ocular sarcoidosis. Br J Ophthalmol 2011; 95 (12) 1731-1734
  • 129 Chevalet P, Clément R, Rodat O, Moreau A, Brisseau JM, Clarke JP. Sarcoidosis diagnosed in elderly subjects: retrospective study of 30 cases. Chest 2004; 126 (5) 1423-1430
  • 130 Teirstein AS, Judson MA, Baughman RP, Rossman MD, Yeager Jr H, Moller DR ; Case Control Etiologic Study of Sarcoidosis (ACCESS) Writing Group. The spectrum of biopsy sites for the diagnosis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22 (2) 139-146
  • 131 Nunes HU, Uzunhan Y, Gille T, Lamberto C, Valeyre D, Brillet PY. Imaging of sarcoidosis of the airways and lung parenchyma with correlation with lung function. Eur Respir J 2012; 40: 750-765
  • 132 Clement DS, Postma G, Rothova A, Grutters JC, Prokop M, de Jong PA. Intraocular sarcoidosis: association of clinical characteristics of uveitis with positive chest high-resolution computed tomography findings. Br J Ophthalmol 2010; 94 (2) 219-222
  • 133 Kaiser PK, Lowder CY, Sullivan P , et al. Chest computerized tomography in the evaluation of uveitis in elderly women. Am J Ophthalmol 2002; 133 (4) 499-505
  • 134 El-Zammar OA, Katzenstein AL. Pathological diagnosis of granulomatous lung disease: a review. Histopathology 2007; 50 (3) 289-310
  • 135 Judson MA. The management of sarcoidosis by the primary care physician. Am J Med 2007; 120 (5) 403-407
  • 136 Müller-Quernheim J, Gaede KI, Fireman E, Zissel G. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J 2006; 27 (6) 1190-1195
  • 137 Hamzeh NY, Wamboldt FS, Weinberger HD. Management of cardiac sarcoidosis in the United States: a Delphi study. Chest 2012; 141 (1) 154-162
  • 138 Maña J, Teirstein AS, Mendelson DS, Padilla ML, DePalo LR. Excessive thoracic computed tomographic scanning in sarcoidosis. Thorax 1995; 50 (12) 1264-1266
  • 139 Bargagli E, Magi B, Olivieri C, Bianchi N, Landi C, Rottoli P. Analysis of serum amyloid A in sarcoidosis patients. Respir Med 2011; 105 (5) 775-780
  • 140 Mostard RL, Van Kuijk SM, Verschakelen JA , et al. A predictive tool for an effective use of (18)F-FDG PET in assessing activity of sarcoidosis. BMC Pulm Med 2012; 12: 57
  • 141 Vorselaars AD, Verwoerd A, van Moorsel CH, Keijsers RG, Rijkers GT, Grutters JC. Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis. Eur Respir J 2014; 43 (2) 602-609
  • 142 Pascual RS, Gee JB, Finch SC. Usefulness of serum lysozyme measurement in diagnosis and evaluation of sarcoidosis. N Engl J Med 1973; 289 (20) 1074-1076
  • 143 Prior C, Barbee RA, Evans PM , et al. Lavage versus serum measurements of lysozyme, angiotensin converting enzyme and other inflammatory markers in pulmonary sarcoidosis. Eur Respir J 1990; 3 (10) 1146-1154
  • 144 Kobayashi J, Kitamura S. Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis. Chest 1996; 109 (5) 1276-1282
  • 145 Honda K, Okada F, Ando Y , et al. Comparison of pulmonary thin section CT findings and serum KL-6 levels in patients with sarcoidosis. Br J Radiol 2011; 84 (999) 229-235
  • 146 Geyer AI, Kraus T, Roberts M , et al. Plasma level of interferon γ induced protein 10 is a marker of sarcoidosis disease activity. Cytokine 2013; 64 (1) 152-157
  • 147 Ueda-Hayakawa I, Tanimura H, Osawa M , et al. Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity. Rheumatology (Oxford) 2013; 52 (9) 1658-1666